An antibiotic selection marker for schistosome transgenesis

Area of Science:

• Parasitology
• Molecular Biology
• Genetics

Background:

• Drug selection is crucial for transgene studies in various organisms.
• Enriching transgenic schistosomes is vital for advancing helminth research.
• Current methods lack efficient drug selection for schistosomes.

Purpose of the Study:

• To establish a drug selection method for creating transgenic schistosomes.
• To adapt retroviral vectors for schistosome gene transfer.
• To demonstrate the enrichment of transgenic schistosomes using G418 selection.

Main Methods:

• Adapted murine leukemia retrovirus vectors for schistosome transduction.
• Determined G418 (geneticin) dose-response and lethal concentrations.
• Cultured transduced schistosomes in G418-containing media to assess neomycin resistance (neoR) transgene efficacy.

Main Results:

• Established lethal G418 concentrations for Schistosoma mansoni schistosomules.
• Demonstrated that the neoR transgene rescues transgenic schistosomes from G418 toxicity.
• Showed dose-dependent enrichment and increased neoR expression in transgenic schistosomes cultured with G418.

Conclusions:

• Successfully adapted retroviral vectors for schistosome transduction.
• Established G418 as an effective drug selection agent for transgenic schistosomes.
• This method will accelerate functional genomics research on neglected tropical disease-causing helminths.